Echo Learning Center

Better + Together. In 2019, Beckman Coulter Life Sciences acquired Labcyte. This powerful merger combined the power of Echo Liquid Handler and Biomek Workstation technologies and officially launched the next wave in flexible liquid handling solutions for drug discovery, sample management, synthetic biology, genomics, proteomics and functional screening workflows.

Discover the highly accurate, fully automated, non-contact transfer of fluids as low as 2.5 nL - all made possible by sound energy. Experience a new level of precision, efficiency and sustainability with the Echo Liquid Handler.

Echo Acoustic Liquid Handlers - Beckman Coulter Life Sciences

Moving Liquids with Sound

 

The Echo Acoustic Liquid Handler:

  • Utilizes Acoustic Droplet Ejection (ADE) technology for accurate and quick transfer of fluids up to 700 drops per second
  • Transfers are non-contact from an Echo compatible source plate to an inverted destination microplate
  • Allows real-time adjustments through Dynamic Fluid Analysis (DFA) for reliable nanoliter transfers, with no intervention required from the user
  • Calculates the depth of fluid in each well and can also analyze fluid types such as DMSO or glycerol percentages
  • Provides 1:1, 1:many, many:1, and complex combinatorial transfers from a compatible source plate to dry or pre-filled destination wells

Learn More

Downloadable Brochures

Videos

Echo Liquid Handler Models

 

Echo Software

 

Citations

  1. Bashore C et al. Targeted degradation via direct 26S proteasome recruitment. Nat Chem Biol. 2023 Jan;19(1):55-63. Epub 2022 Dec 28. PMID: 36577875
  2. Ma S et al. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. Nat Commun. 2022 Feb 25;13(1):1061. PMID: 35217640
  3. Pal R, Seleem MN. Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo. PLoS One. 2022 Aug 8;17(8):e0267859. PMID: 35939437
  4. Papandreou A et al. Automated High-Content Imaging in iPSC-derived Neuronal Progenitors. SLAS Discov. 2023 Jan 4:S2472-5552(22)13715-9. PMID: 36610640
  5. Riva L et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 Oct;586(7827):113-119. Epub 2020 Jul 24. PMID: 32707573
  1. Li J et al. DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery. ACS Chem Biol. 2022 Jun 17;17(6):1401-1414. Epub 2022 May 4. PMID: 35508359
  2. Nyffeler J et al. Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: Retinoic acid as an example. Toxicol Appl Pharmacol. 2022 Jun 1;444:116032. Epub 2022 Apr 26. PMID: 35483669
  1. Bousgouni V, Bakal C. Quantitative imaging of single-cell phenotypes in cancer cells cultured on hydrogel surfaces. STAR Protoc. 2022 Dec 15;4(1):101942. doi: 10.1016/j.xpro.2022.101942. Epub ahead of print. PMID: 36525347
  2. Denisova OV et al. Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells. Sci Rep. 2022 Aug 13;12(1):13796. doi: 10.1038/s41598-022-18118-7. PMID: 35963891
  3. Ross-Thriepland D et al. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles. SLAS Discov. 2020 Jul;25(6):605-617. doi: 10.1177/2472555220925770. Epub 2020 May 22. PMID: 32441189
  1. Bashore C et al. Targeted degradation via direct 26S proteasome recruitment. Nat Chem Biol. 2023 Jan;19(1):55-63. Epub 2022 Dec 28. PMID: 36577875
  2. Ma S et al. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. Nat Commun. 2022 Feb 25;13(1):1061. PMID: 35217640
  3. Pal R, Seleem MN. Discovery of a novel natural product inhibitor of Clostridioides difficile with potent activity in vitro and in vivo. PLoS One. 2022 Aug 8;17(8):e0267859. PMID: 35939437
  4. Papandreou A et al. Automated High-Content Imaging in iPSC-derived Neuronal Progenitors. SLAS Discov. 2023 Jan 4:S2472-5552(22)13715-9. PMID: 36610640
  5. Riva L et al. Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing. Nature. 2020 Oct;586(7827):113-119. Epub 2020 Jul 24. PMID: 32707573
  1. Li J et al DRUG-seq Provides Unbiased Biological Activity Readouts for Neuroscience Drug Discovery. ACS Chem Biol. 2022 Jun 17;17(6):1401-1414. Epub 2022 May 4. PMID: 35508359
  2. Nyffeler J et al. Combining phenotypic profiling and targeted RNA-Seq reveals linkages between transcriptional perturbations and chemical effects on cell morphology: Retinoic acid as an example. Toxicol Appl Pharmacol. 2022 Jun 1;444:116032. Epub 2022 Apr 26. PMID: 35483669
  1. Bousgouni V, Bakal C. Quantitative imaging of single-cell phenotypes in cancer cells cultured on hydrogel surfaces. STAR Protoc. 2022 Dec 15;4(1):101942. doi: 10.1016/j.xpro.2022.101942. Epub ahead of print. PMID: 36525347
  2. Denisova OV et al. Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells. Sci Rep. 2022 Aug 13;12(1):13796. doi: 10.1038/s41598-022-18118-7. PMID: 35963891
  3. Ross-Thriepland D et al. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles. SLAS Discov. 2020 Jul;25(6):605-617. doi: 10.1177/2472555220925770. Epub 2020 May 22. PMID: 32441189

Contact Us

Whether you have questions or are ready to request a quote, we're here to help. What can we do for you today?

These products are not intended or validated for use in the diagnosis of disease or other conditions.
©2023 Beckman Coulter, Inc. All rights reserved. Beckman Coulter, the Stylized Logo, and Beckman Coulter product and service marks mentioned herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. ECHO is a trademark or registered trademark of Labcyte Inc. in the United States and other countries. Labcyte is a Beckman Coulter company. All other trademarks are the property of their respective owners.